$45.98
-1.04-2.21%
At close: -
$45.98
00.00%
After Hours: 5:28 PM EDT
Comments
Loading...
Kymera Therapeutics (KYMR) Forecast
NewsEarningsKymera Therapeutics (KYMR) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestKymera Therapeutics (NASDAQ:KYMR) Stock Quotes, Forecast and News Summary
Kymera Therapeutics Stock (NASDAQ: KYMR) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Kymera Therapeutics (KYMR) stock?
You can purchase shares of Kymera Therapeutics (NASDAQ:KYMR) through any online brokerage.
Who are Kymera Therapeutics (KYMR) competitors?
Other companies in Kymera Therapeutics’s space includes: Immunovant (NASDAQ:IMVT), Twist Bioscience (NASDAQ:TWST), Ultragenyx Pharmaceutical (NASDAQ:RARE), MoonLake (NASDAQ:MLTX) and SpringWorks Therapeutics (NASDAQ:SWTX).
What is the forecast, or price target, for Kymera Therapeutics (KYMR) stock?
Kymera Therapeutics has a consensus price target of $49.14.
What is the current price for Kymera Therapeutics (KYMR)?
The stock price for Kymera Therapeutics (NASDAQ: KYMR) is $45.98 last updated November 26, 2024 at 5:28 PM EST.
Does Kymera Therapeutics (KYMR) pay a dividend?
There are no upcoming dividends for Kymera Therapeutics.
When is Kymera Therapeutics (NASDAQ:KYMR) reporting earnings?
Kymera Therapeutics’s Q4 earnings are confirmed for Thursday, February 20, 2025.
Is Kymera Therapeutics (KYMR) going to split?
There is no upcoming split for Kymera Therapeutics.
What sector and industry does Kymera Therapeutics (KYMR) operate in?
Kymera Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.